Trace Biosciences creates fluorescence imaging agents for real-time nerve visualization during surgery.
Trace Biosciences has raised $150K in total funding. The most recent round was Grant. The last funding was announced in December 2024.
Trace Biosciences's investors include National Science Foundation, Advanced Research Projects Agency for Health, National Institutes of Health, SciFounders, National Institute of Health.
Trace Biosciences is headquartered in Beaverton, United States.
Trace Biosciences creates fluorescence imaging agents for real-time nerve visualization during surgery.
Trace Biosciences is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Trace Biosciences — Funding & Investors." VCBacked, December 20, 2024, https://www.vcbacked.co/company/trace-biosciences. Accessed July 19, 2026.
VCBacked. (2024). Trace Biosciences — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/trace-biosciences
{{cite web |title=Trace Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/trace-biosciences |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated